Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Buse

Showing results (91-100 of 457) with videos related to

Pageof 46
Sort By:
Biomacromolecules|October 1, 2014
Bio-inspired synthetic nanovesicles for glucose-responsive release of insulinWanyi Tai, Ran Mo, Jin Di, et al.
Diabetes|June 10, 2024
Recent Progress in Glucose-Responsive InsulinYun Liu, Shiqi Wang, Zejun Wang, et al.
Diabetologia|May 25, 2016
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trialsRalph A DeFronzo, John B Buse, Terri Kim, et al.
Journal of the Endocrine Society|April 30, 2021
Carbohydrate Intake Prior to Oral Glucose Tolerance TestingKlara R Klein, Christopher P Walker, Amber L McFerren, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 22, 2025
Time to Treatment Intensification with Glucagon-Like Peptide-1 Receptor Agonists Versus Comparators in People with Type 2 Diabetes Treated with MetforminJohn W Ostrominski, Vanita R Aroda, Uffe C Braae, et al.
Diabetes Care|April 25, 2025
High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 TrialVanita R Aroda, Nils B Jørgensen, Bharath Kumar, et al.
Diabetes, Obesity & Metabolism|February 19, 2021
Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutideSubodh Verma, Udi Fainberg, Mansoor Husain, et al.
Diabetes Care|July 21, 2022
Antihyperglycemic Medication Use Among U.S. Adults With Hemodialysis-Dependent Kidney Disease and Comorbid DiabetesKlara R Klein, Virginia Pate, Magdalene M Assimon, et al.
Diabetes Care|October 9, 2021
COVID-19, Hyperglycemia, and New-Onset DiabetesKamlesh Khunti, Stefano Del Prato, Chantal Mathieu, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|February 25, 2021
Comparison of Protocols to Reduce Diabetic Ketoacidosis in Patients With Type 1 Diabetes Prescribed a Sodium-Glucose Cotransporter 2 InhibitorRhea Teng, Martin Kurian, Kelly L Close, et al.
Pageof 46

Showing results (91-100 of 457) with videos related to

Sort By:
Pageof 46
Biomacromolecules|October 1, 2014
Bio-inspired synthetic nanovesicles for glucose-responsive release of insulinWanyi Tai, Ran Mo, Jin Di, et al.
Diabetes|June 10, 2024
Recent Progress in Glucose-Responsive InsulinYun Liu, Shiqi Wang, Zejun Wang, et al.
Diabetologia|May 25, 2016
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trialsRalph A DeFronzo, John B Buse, Terri Kim, et al.
Journal of the Endocrine Society|April 30, 2021
Carbohydrate Intake Prior to Oral Glucose Tolerance TestingKlara R Klein, Christopher P Walker, Amber L McFerren, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 22, 2025
Time to Treatment Intensification with Glucagon-Like Peptide-1 Receptor Agonists Versus Comparators in People with Type 2 Diabetes Treated with MetforminJohn W Ostrominski, Vanita R Aroda, Uffe C Braae, et al.
Diabetes Care|April 25, 2025
High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 TrialVanita R Aroda, Nils B Jørgensen, Bharath Kumar, et al.
Diabetes, Obesity & Metabolism|February 19, 2021
Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutideSubodh Verma, Udi Fainberg, Mansoor Husain, et al.
Diabetes Care|July 21, 2022
Antihyperglycemic Medication Use Among U.S. Adults With Hemodialysis-Dependent Kidney Disease and Comorbid DiabetesKlara R Klein, Virginia Pate, Magdalene M Assimon, et al.
Diabetes Care|October 9, 2021
COVID-19, Hyperglycemia, and New-Onset DiabetesKamlesh Khunti, Stefano Del Prato, Chantal Mathieu, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|February 25, 2021
Comparison of Protocols to Reduce Diabetic Ketoacidosis in Patients With Type 1 Diabetes Prescribed a Sodium-Glucose Cotransporter 2 InhibitorRhea Teng, Martin Kurian, Kelly L Close, et al.
Pageof 46